1366 B7-H3xCD3 bispecific antibody as novel treatment option in HER2-negative breast cancer
Ilona Hagelstein,
Gundram Jung,
Helmut R Salih,
Latifa Zekri,
Martina S Lutz,
Laura Weßling,
Christian M Tegeler
Affiliations
Ilona Hagelstein
1Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany
Gundram Jung
Eberhard Karls University, Tuebingen, Baden-Wuerttemberg, Germany
Helmut R Salih
1Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany
Latifa Zekri
Eberhard Karls University, Tuebingen, Baden-Wuerttemberg, Germany
Martina S Lutz
Eberhard Karls University, Tuebingen, Baden-Wuerttemberg, Germany
